GREMPAL
Grup de Recerca en Malalties Prevalents de l´Aparell Locomotor en Atenció Primària (GREMPAL)

Group leader
fundanet_file_Investigador4053-2
Daniel Martínez Laguna
dmartinezl.bcn.ics@gencat.cat
avatar_grups_recerca.png

Publications

Impact of the COVID-19 pandemic on diagnoses of common mental health disorders in adults in Catalonia, Spain: a population-based cohort study

B. RAVENTOS, A. PISTILLO, C. REYES, S. FERNANDEZ-BERTOLIN, M. ARAGON, A. BERENGUERA, C. JACQUES-AVINO, L. MEDINA-PERUCHA, E. BURN and T. DUARTE-SALLES
BMJ Open. 2022 Apr 1; . doi:10.1136/bmjopen-2021-057866; PMID:35396302

Association between covid-19 vaccination, SARS-CoV-2 infection, and risk of immune mediated neurological events: population based cohort and self-controlled case series analysis

X. LI, B. RAVENTOS, E. ROEL, A. PISTILLO, E. MARTINEZ-HERNANDEZ, A. DELMESTRI, C. REYES, V. STRAUSS, D. PRIETO-ALHAMBRA, E. BURN and T. DUARTE-SALLES
BMJ-BRITISH MEDICAL JOURNAL. 2022 Mar 16; . doi:10.1136/bmj-2021-068373; PMID:35296468

  • Any: 16/03/2022
  • FI: 105.7
  • Article

Association of Tramadol vs Codeine Prescription Dispensation With Mortality and Other Adverse Outcomes Reply

J. XIE, C. REYES and D. PRIETO-ALHAMBRA
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION. 2022 Feb 1; . doi:10.1001/jama.2021.23126; PMID:35103768

  • Any: 01/02/2022
  • FI: 120.7
  • Article

Feasibility of a Federated Network Analysis Using Real-World Data Mapped to OMOP Common Data Model to Estimate Healthcare Resource Utilisation and Costs of Imminent Subsequent Fracture

G. FABIANO, X. CHEN, T. RATHOD-MISTRY, A. DELMESTRI, L. NJUKI, A. MOAYYERI, J. WARDEN, C. REYES, J. BRASH, K. VERHAMME, E. TAN and R. PINEDO-VILLANUEVA
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY. 2024 Nov 1;

Prescription Sequence Symmetry Analysis to Identify Prescription Cascades for Dementia Drug Treatments in the United Kingdom

B. RAVENTÓS, X. CHEN, T. STANFORD, D. PRIETO-ALHAMBRA, L. PORCE, C. REYES, T. DUARTE-SALLES, E. BURN, M. CATALÀ, N. PRATT, A. JÖDICKE and D. NEWBY
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY. 2024 Nov 1;